Hidradenitis Suppurativa News

Izokibep exhibited statistically significant improvement in hidradenitis suppurativa, according to topline phase 3 trial results announced in a press release by Affibody and Acelyrin.

The European Commission has granted marketing authorization for two devices that administer Bimzelx for the treatment of multiple inflammatory diseases, UCB announced in a press release.

Poor representation of darker skin tones in dermatology training materials has led to delayed diagnoses and worse treatment outcomes in Black, Asian and non-white Latin American patients, according to a presenter.

Healio has compiled July’s most-read news in dermatology.

Healio has compiled June’s most-read news in dermatology.

The Global Hidradenitis Suppurativa Atlas has produced a report offering the first global data on the diagnosis, impact and treatment of hidradenitis suppurativa, according to a press release.

CLEVELAND — Hidradenitis suppurativa research has hit roadblocks including high placebo responses and difficulty in accurate assessments, according to Amit Garg, MD, professor and chair of the department of dermatology at Northwell Health.

Patients treated with bimekizumab for moderate to severe hidradenitis suppurativa exhibited rapid and clinically meaningful responses that were maintained up to 48 weeks, according to new data published in The Lancet.

Simlandi injection, an interchangeable biosimilar to Humira, is now available in the U.S. for the treatment of psoriatic arthritis, plaque psoriasis and other conditions, Teva Pharmaceuticals and Alvotech announced in a press release.

The FDA has approved a citrate-free, high-concentration formulation of the interchangeable adalimumab biosimilar Cyltezo to treat multiple chronic inflammatory diseases, according to the manufacturer.